MS News & Perspectives

MS News & Perspectives

Multiple Sclerosis News Today seeks to fill an unmet need in healthcare news journalism by providing patients and their families with a reliable news journal on MS that they can engage with on a daily basis for the latest news and MS resources.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(500)

Jenn Chats to Author Melissa Cook

Jenn Chats to Author Melissa Cook

Imagine living with MS with no nearby services and the closest medical care a 3-hour flight away. Melissa Cook spent 20 years managing her disease remotely and chronicling her daily experiences in he...

26 Jan 202330min

Alcohol Consumption Is No Protection From MS & The Gift of Grace With MS

Alcohol Consumption Is No Protection From MS & The Gift of Grace With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a U.K. study reporting that the risk of developing multiple sclerosis was not influenced by the consumption of alcoh...

16 Jan 20238min

Ublituximab Approved for Relapsing Forms of MS & A Multiple Sclerosis Parody

Ublituximab Approved for Relapsing Forms of MS & A Multiple Sclerosis Parody

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about the B-cell depleting therapy Briumvi (ublituximab) being approved in the U.S. for adults with relapsi...

13 Jan 202311min

Trial Testing Ginger Supplements in RRMS & Embracing the Highs and Lows of MS

Trial Testing Ginger Supplements in RRMS & Embracing the Highs and Lows of MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about new clinical trial in Iran testing the effects of ginger supplements in patients with RRMS.
 He also ...

11 Jan 202310min

FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a masitinib trial that is expected to include up to 800 participants at about 75 sites in Europe, Nor...

9 Jan 202310min

Cutting Brain-gut Vagus Nerve Lessens Loss of Myelin & Hip Pain and Steroid Treatments

Cutting Brain-gut Vagus Nerve Lessens Loss of Myelin & Hip Pain and Steroid Treatments

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how severing the lower part of the vagus nerve that connects the brain and gut led to less myelin loss i...

6 Jan 202310min

Walking Difficulties Improve With Natural Supplement & Brain Stimulation and Other MS News

Walking Difficulties Improve With Natural Supplement & Brain Stimulation and Other MS News

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news about a natural supplement from Persian medicine that led to improvements in physical activity for MS patients wi...

4 Jan 20239min

Early MS Symptoms May Predict Disease Course & Copaxone and Other MS News

Early MS Symptoms May Predict Disease Course & Copaxone and Other MS News

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting on how symptoms that are evident before MS begins could help predict disease type and likely cour...

2 Jan 20239min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
sinnsyn
liberal-halvtime
forskningno
jss
fjellsportpodden
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
dekodet-2
rss-overskuddsliv
rss-inn-til-kjernen-med-sunniva-rose
rss-zahid-ali-hjelper-deg
villmarksliv
nevropodden
rss-rekommandert
hva-er-greia-med
kvinnehelsepodden
vett-og-vitenskap-med-gaute-einevoll